Patent · US Expired

Betulinic acid derivatives for inhabiting cancer growth and process for the manufacture of betulinic acid

US6670345B1 · kind B1 · utility

10Cited by
6References
15Claims
0Family size

Assignee

Inventors

Key dates

Filing dateNov 2, 1999
Grant dateDec 30, 2003
Priority date
Expiry dateNov 2, 2019

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07J63/008
  • WIPO fieldOrganic fine chemistry
  • WIPO sectorChemistry

Abstract

The invention relates to the use of betulinic acid derivatives for the inhibition and or prevention of cancer growth. The invention also relates to novel betulinic acid derivatives useful for inhibition of tumor cancer cells and a process for the preparation of the derivatives. The invention also relates to anti-leukemic and anti-lymphoma activity of the betulinic acid derivatives, and the use of the derivatives for the treatment of prostate, lung, laryngeal, colon and ovarian cancer.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.